financetom
Business
financetom
/
Business
/
Centessa Pharmaceuticals Insider Sold Shares Worth $719,940, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Centessa Pharmaceuticals Insider Sold Shares Worth $719,940, According to a Recent SEC Filing
Mar 27, 2026 1:39 AM

04:21 AM EDT, 03/27/2026 (MT Newswires) -- Gregory M Weinhoff, Chief Business Officer, on March 26, 2026, sold 23,998 shares in Centessa Pharmaceuticals ( CNTA ) for $719,940. Following the Form 4 filing with the SEC, Weinhoff has control over a total of 65,925 ordinary shares of the company, with 65,925 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1847903/000147083126000320/xslF345X05/wk-form4_1774571761.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved